DE69013959D1 - Aminobenzolsulfonsäurederivate. - Google Patents

Aminobenzolsulfonsäurederivate.

Info

Publication number
DE69013959D1
DE69013959D1 DE69013959T DE69013959T DE69013959D1 DE 69013959 D1 DE69013959 D1 DE 69013959D1 DE 69013959 T DE69013959 T DE 69013959T DE 69013959 T DE69013959 T DE 69013959T DE 69013959 D1 DE69013959 D1 DE 69013959D1
Authority
DE
Germany
Prior art keywords
group
aminobenzenesulfonic acid
acid derivatives
alkyl group
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69013959T
Other languages
English (en)
Other versions
DE69013959T2 (de
Inventor
Hiromi Okushima
Akihiro Narimatsu
Makio Kobayashi
Naoya Satoh
Miyuki Morita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Publication of DE69013959D1 publication Critical patent/DE69013959D1/de
Application granted granted Critical
Publication of DE69013959T2 publication Critical patent/DE69013959T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69013959T 1989-03-27 1990-03-22 Aminobenzolsulfonsäurederivate. Expired - Lifetime DE69013959T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7468489 1989-03-27
JP2064811A JPH0686438B2 (ja) 1989-03-27 1990-03-15 アミノベンゼンスルホン酸誘導体

Publications (2)

Publication Number Publication Date
DE69013959D1 true DE69013959D1 (de) 1994-12-15
DE69013959T2 DE69013959T2 (de) 1995-03-16

Family

ID=26405909

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69013959T Expired - Lifetime DE69013959T2 (de) 1989-03-27 1990-03-22 Aminobenzolsulfonsäurederivate.

Country Status (7)

Country Link
EP (1) EP0390654B1 (de)
JP (1) JPH0686438B2 (de)
AT (1) ATE113940T1 (de)
CA (1) CA2013037C (de)
DE (1) DE69013959T2 (de)
DK (1) DK0390654T3 (de)
ES (1) ES2063300T3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192731C (en) 1995-12-15 2005-09-27 Chika Yamazaki Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
US5965560A (en) * 1996-04-30 1999-10-12 Warner-Lambert Company Substituted piperazines and piperidines as central nervous system agents
US5859246A (en) * 1997-01-30 1999-01-12 Neurogen Corporation 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
CN1109677C (zh) * 1997-06-13 2003-05-28 三菱化学株式会社 氨基苯磺酸衍生物的单水合物及其制备方法
US6407113B1 (en) 1998-02-12 2002-06-18 Mitsubishi Chemical Corporation Medicament for treatment of diastolic dysfunction
WO1999040919A1 (fr) * 1998-02-12 1999-08-19 Mitsubishi Chemical Corporation Medicaments contre les troubles diastoliques cardiaques
ATE284711T1 (de) 1999-12-21 2005-01-15 Mitsubishi Pharma Corp Heilmittel und/oder prophylactische mittel zur behandlung von nervensystem-störungen
JP2004516239A (ja) 2000-07-06 2004-06-03 ニューロジェン コーポレイション メラニン凝集ホルモン受容体リガンド
US20050124632A1 (en) * 2001-03-13 2005-06-09 Yoshimi Kitada Remedies and/or preventives for diabetic ischemic heart diseases
CN1703401A (zh) 2001-05-22 2005-11-30 神经原公司 黑色素浓集激素受体的配体:取代的1－苄基－4－芳基哌嗪类似物
AR034887A1 (es) * 2001-07-25 2004-03-24 Mitsubishi Pharma Corp Medicamento inhibidor del sistema de intercambio sodio/calcio
JPWO2003011296A1 (ja) * 2001-07-30 2004-11-18 三菱ウェルファーマ株式会社 アミノベンゼンスルホン酸誘導体を活性成分とする医薬品製剤
AU2003261815A1 (en) * 2002-08-30 2004-03-19 Mitsubishi Pharma Corporation Inhibitors for excessive accumulation of sodium ion in cells
WO2004022545A1 (ja) * 2002-09-06 2004-03-18 Mitsubishi Pharma Corporation 移植臓器保護剤
WO2004069275A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation 眼科用剤
US20070270409A1 (en) * 2004-03-05 2007-11-22 Mitsubishi Pharma Corporation Medicament for Preventing and/or Treating Ischemic Cardiovascular Disease
WO2005110982A2 (en) 2004-04-07 2005-11-24 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
US20100004266A1 (en) * 2006-07-21 2010-01-07 Mitsubishi Tanabe Pharma Corporation Salt or Solvate of 5-Methyl-2(Piperazin-1-Yl)Benzenesulfonic Acid
JPWO2008010566A1 (ja) * 2006-07-21 2009-12-17 田辺三菱製薬株式会社 ５−メチル‐２‐（ピペラジン−１−イル）ベンゼンスルホン酸の結晶多形
WO2008032814A1 (fr) * 2006-09-14 2008-03-20 Mitsubishi Tanabe Pharma Corporation Agent pharmaceutique contenant de l'aspirine
EP2564259B1 (de) 2010-04-30 2015-01-21 Beijing Institute Of Technology Kopfmontierte hochauflösende weitwinkel- und mosaikanzeigevorrichtung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1104514B (de) * 1955-06-29 1961-04-13 Parke Davis & Co Verfahren zur Herstellung von blutdrucksenkend wirkenden 1-Mercaptophenyl-4-piperazino-alkoholen
DE2040279A1 (de) * 1970-08-13 1972-02-17 Hoechst Ag Verfahren zur Herstellung basisch substituierter Benzolsulfonamide
DE2111811A1 (de) * 1971-03-12 1972-09-14 Hoechst Ag Basisch substituierte Benzolsulfonylformamidine und Verfahren zu ihrer Herstellung
DE3715763A1 (de) * 1987-05-12 1988-11-24 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
ATE113940T1 (de) 1994-11-15
CA2013037C (en) 1999-12-07
ES2063300T3 (es) 1995-01-01
DK0390654T3 (da) 1995-04-03
JPH0686438B2 (ja) 1994-11-02
DE69013959T2 (de) 1995-03-16
CA2013037A1 (en) 1990-09-27
EP0390654B1 (de) 1994-11-09
EP0390654A1 (de) 1990-10-03
JPH037263A (ja) 1991-01-14

Similar Documents

Publication Publication Date Title
DE69013959D1 (de) Aminobenzolsulfonsäurederivate.
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
DK0850926T3 (da) Difluorprostaglandinderivater og deres anvendelse
AU657106B2 (en) Preparation and use of N-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents
PT918776E (pt) Sintese total de acilfulvenos antitumorais
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
MX9100227A (es) Derivados de cefalosporina y procedimiento para su preparacion.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
FI884088A0 (fi) Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat.
HK1003890A1 (en) Optically active thiazolidinone derivatives
EP0785190A3 (de)
AU623500B2 (en) Carboxylimino benzothiazole derivatives
NO883387D0 (no) Fremgangsmaate for fremstilling av 2'-deoksy-5-fluoruridinderivater.
ES2032214T3 (es) Un procedimiento para la preparacion de un derivado de ergolina.
DE68919869D1 (de) Cephalosporinderivate.
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
BR9305092A (pt) Processo para a preparação de derivados de 5-pirazolmercáptan, composto ditiocarbazato de etilideno, processo para a preparação de derivados do mesmo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI CHEMICAL CORP., TOKIO/TOKYO, JP